Last updated – November 1
The situation with coronavirus (COVID-19) is changing rapidly across Canada. The MS Society of Canada is closely monitoring information on COVID-19 as released by the Public Health Agency of Canada and other public health authorities. The health of the MS community is our priority as we manage through concerns related to COVID-19.
The MS International Federation (MSIF) released an updated version of the Global COVID-19 advice for people with MS on June 4, 2021.
Coronavirus 2019 (COVID-19) is a respiratory illness that can spread from person to person. Currently, it’s unclear how easily the virus that causes COVID-19 is spreading between people.
Most people who contract COVID-19 will have mild symptoms, but some people will have more severe symptoms. Symptoms can include:
There are simple everyday preventive actions to help prevent the spread of respiratory viruses. These include:
Many disease-modifying therapies (DMTs) for MS work by modifying or suppressing the immune system. People with MS who are treated with these therapies can face an increased risk of infections. If you are taking a DMT and have concerns about your risk for COVID-19, do not stop your DMT without first speaking with your MS and primary care provider.
If you have been in close contact with a person known to have COVID-19 or believe you have otherwise been exposed to COVID-19 or are confirmed to have this infection, stay home and contact your MS and primary care provider for advice right away.
Call your MS and primary care provider if you have recently traveled from an area with widespread or ongoing community spread of COVID-19.
For more information please visit the Disease-Modifying Treatment (DMT) Guidelines for Coronavirus (COVID-19) page.
How to navigate a virtual care visit: patient guide from the Canadian Medical Association
Adapted from the National MS Society